4.5 Article

Targeting RPTPσ with lentiviral shRNA promotes neurites outgrowth of cortical neurons and improves functional recovery in a rat spinal cord contusion model

期刊

BRAIN RESEARCH
卷 1586, 期 -, 页码 46-63

出版社

ELSEVIER
DOI: 10.1016/j.brainres.2014.08.048

关键词

RPTP sigma; RNA interference; Axon regeneration; Functional recovery; Spinal cord injury

资金

  1. National Natural Science Foundation of China [81070982, 81201400]
  2. State Key Program of National Natural Science Foundation of China [81330042]
  3. Tianjin Research Program of Application Foundation and Advanced Technology [13JCQNJC11100]

向作者/读者索取更多资源

After spinal cord injury (SCI), the rapidly upregulated chondroitin sulfate proteoglycans (CSPGs), the prominent chemical constituents and main repulsive factors of the glial scar, play an important role in the extremely limited ability to regenerate in adult mammals. Although many methods to overcome the inhibition have been tested, no successful method with clinical feasibility has been devised to date. It was recently discovered that receptor protein tyrosine phosphatase sigma (RPTP sigma) is a functional receptor for CSPGs-mediated inhibition. In view of the potential clinical application of RNA interference (RNAi), here we investigated whether silencing RPTP sigma via lentivirus-mediated RNA interference can promote axon regeneration and functional recovery after SCI. Neurites of primary rat cerebral cortical neurons with depleted RPTP sigma exhibited a significant enhancement in elongation and crossing ability when they encountered CSPGs in vitro. A contusion model of spinal cord injury in Wistar rats (the New York University (NYU) impactor) was used for in vivo experiments. Local injection of lentivirus encoding RPTP sigma shRNA at the lesion site promoted axon regeneration and synapse formation, but did not affect the scar formation. Meanwhile, in vivo functional recovery (motor and sensory) was also enhanced after RPTP sigma depletion. Therefore, strategies directed at silencing RPTP sigma by RNAi may prove to be a beneficial, efficient and valuable approach for the treatment of SCI. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据